Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management
作者： Ayalew Tefferi , Tiziano Barbui
DOI: 10.1002/AJH.23895
关键词: Leukemia 、 Thrombocytosis 、 Immunology 、 Essential thrombocythemia 、 Polycythemia vera 、 Gastroenterology 、 Leukocytosis 、 Myelofibrosis 、 Internal medicine 、 Janus kinase 2 、 Medicine 、 Survival analysis
摘要: … CV risk factors as additional risk factors for thrombosis in ET does not necessarily change how we currently risk … are the two risk factors used to classify patients with PV or ET into low (0 …
elsevier.com
sci-hub.se 参考文章(120)
Yvon Sterkers, Claude Preudhomme, Jean-Luc Laı̈, Jean-Loup Demory, Marie-Thérèse Caulier, Eric Wattel, Dominique Bordessoule, Francis Bauters, Pierre Fenaux, Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. Blood. ,vol. 91, pp. 616- 622 ,(1998) , 10.1182/BLOOD.V91.2.616
Goldberg Jd, Wasserman Lr, Berk Pd, Tartaglia Ap, Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera. Seminars in Hematology. ,vol. 23, pp. 172- 176 ,(1986)
U Budde, G Schaefer, N Mueller, H Egli, J Dent, Z Ruggeri, T Zimmerman, Acquired von Willebrand's disease in the myeloproliferative syndrome Blood. ,vol. 64, pp. 981- 985 ,(1984) , 10.1182/BLOOD.V64.5.981.981
R Sharon, I Tatarsky, Management of polycythemia vera with hydroxyurea. Seminars in Hematology. ,vol. 34, pp. 24- 28 ,(1997)
WILK O. WEST, Hydroxyurea in the treatment of polycythemia vera: a prospective study of 100 patients over a 20-year period. Southern Medical Journal. ,vol. 80, pp. 323- 327 ,(1987) , 10.1097/00007611-198703000-00012
Yves Najean, Jean-Didier Rain, Treatment of Polycythemia Vera: The Use of Hydroxyurea and Pipobroman in 292 Patients Under the Age of 65 Years Blood. ,vol. 90, pp. 3370- 3377 ,(1997) , 10.1182/BLOOD.V90.9.3370
Tiziano Barbui, Jürgen Thiele, Alessandra Carobbio, Paola Guglielmelli, Alessandro Rambaldi, Alessandro M. Vannucchi, Ayalew Tefferi, Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients. American Journal of Hematology. ,vol. 89, pp. 588- 590 ,(2014) , 10.1002/AJH.23694
Ayalew Tefferi, Emnet A. Wassie, Paola Guglielmelli, Naseema Gangat, Alem A. Belachew, Terra L. Lasho, Christy Finke, Rhett P. Ketterling, Curtis A. Hanson, Animesh Pardanani, Alexandra P. Wolanskyj, Margherita Maffioli, Rosario Casalone, Annalisa Pacilli, Alessandro M. Vannucchi, Francesco Passamonti, Type 1 Versus Type 2 Calreticulin Mutations in Essential Thrombocythemia: A Collaborative Study of 1027 Patients American Journal of Hematology. ,vol. 89, ,(2014) , 10.1002/AJH.23743
Perry J J Van Genderen, Jan J Michiels, Roel Van Strik, Jan Lindemans, Huub H D M Van Vliet, Platelet consumption in thrombocythemia complicated by erythromelalgia: reversal by aspirin. Thrombosis and Haemostasis. ,vol. 73, pp. 210- 214 ,(1995) , 10.1055/S-0038-1653752
Perry J J van Genderen, Irene S Lucas, Roel van Strik, Vojislav D Vuzevski, Fransisco J Prins, Huub H D M van Vliet, Jan J Michiels, Erythromelalgia in essential thrombocythemia is characterized by platelet activation and endothelial cell damage but not by thrombin generation Thrombosis and Haemostasis. ,vol. 76, pp. 333- 338 ,(1996) , 10.1055/S-0038-1650579